| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/27/2001 | EP1109904A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109828A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants |
| 06/27/2001 | EP1109818A1 Phosphoepoxides, method for making same and uses |
| 06/27/2001 | EP1109817A1 Phosphohalohydrins, method for making same and uses |
| 06/27/2001 | EP1109815A1 Chemokine receptor antagonists and methods of use therefor |
| 06/27/2001 | EP1109804A1 Chemokine receptor antagonists and methods of use therefor |
| 06/27/2001 | EP1109803A1 Substituted imidazoles having cytokine inhibitory activity |
| 06/27/2001 | EP1109789A1 Triptolide prodrugs having high aqueous solubility |
| 06/27/2001 | EP1109777A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/27/2001 | EP1109577A1 Multicomponent vaccines |
| 06/27/2001 | EP1109576A2 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
| 06/27/2001 | EP1109571A2 Methods of treating hypertension and compositions for use therein |
| 06/27/2001 | EP1109565A1 Gabab1aa receptor |
| 06/27/2001 | EP1109554A2 Pipecolic acid derivatives for vision and memory disorders |
| 06/27/2001 | EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 06/27/2001 | EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 06/27/2001 | EP1109529A1 Lipid extract of the skeletonema algae |
| 06/27/2001 | EP0701554B1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 06/27/2001 | EP0572454B1 Process for the preparation of 29-desmethylrapamycin and its use as antifungal or immunosuppressant agent |
| 06/27/2001 | CN1301271A Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 06/27/2001 | CN1301269A Template associated NPY Y2-receptor agonists |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301176A Use of active P40 conjugates for nasal delivery |
| 06/27/2001 | CN1301171A Cyclosporin preparations |
| 06/27/2001 | CN1301158A Compositions for the treatment of HIV and other viral infections |
| 06/27/2001 | CN1301157A Sustained release preparations |
| 06/27/2001 | CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1301131A Dipeptide apoptosis inhibitors and the use thereof |
| 06/27/2001 | CN1300848A Polypeptide-nagarase 9 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300754A Polypeptide-myb protein 9 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300745A Polypeptide-ring finger protein 8 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300624A Medicine 'Wangyoujianbao' |
| 06/27/2001 | CN1300605A Medicine for treating allergic rhinitis |
| 06/27/2001 | CN1300604A Compound forest frog fat medicine for improving immune function and it spreparing process |
| 06/27/2001 | CN1300595A Nucleic acid oral liquid for animals and its preparing process |
| 06/27/2001 | CN1300590A Use of coating as taste masking agent for oral preparation |
| 06/27/2001 | CN1067570C Chinese medicine for AIDS and preparing process therefor |
| 06/27/2001 | CN1067560C Compounded Chinese meldicinal preparation containing ginseng and american ginseng and preparation method thereof |
| 06/27/2001 | CN1067551C Preparation of high-immunity pig-sourced serum resisting main infectious diseases of chicken |
| 06/26/2001 | US6253104 Method of preparing pharmaceutical Moxa extract and apparatus for electrical moxibustion using the same extract |
| 06/26/2001 | US6252055 Generating immunoglobulins; filter immunoglobulin solution through membrane, cycle filtrate through membrane, recover immunoglobulin |
| 06/26/2001 | US6252044 Riboflavin synthase polypeptide; for the controlled biosynthesis of riboflavin; for screening bactericides; for prevention of infection |
| 06/26/2001 | US6251940 Administering to the mammal suffering from a diseases responsive to inhibit monocyte and/or macrophase and/or lymphocyte activation and of lymphocyte proliferation an amide derivative |
| 06/26/2001 | US6251914 Treating cytokine mediated diseases |
| 06/26/2001 | US6251913 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 06/26/2001 | US6251909 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 06/26/2001 | US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/26/2001 | US6251868 Method for treating a human immunodeficiency virus infection |
| 06/26/2001 | US6251853 Pertussis toxin (ptx); beta-3 subunit of human g protein with not more than six wd repeat motifs; for the diagnosis of disorders, such as a disease associated with g protein dysregulation (i.e. hypertension) |
| 06/26/2001 | US6251663 Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides |
| 06/26/2001 | US6251398 Fusion proteins comprising transport proteins comprising sequences from herpesviral vp22 or fragments thereof together with an antigenic sequence greater than 12 amino acids in length |
| 06/26/2001 | US6251396 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 06/26/2001 | US6251389 Human nucleotide pyrophosphohydrolase-2 |
| 06/26/2001 | US6251388 Utilization of Wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence |
| 06/26/2001 | US6251387 Topoisomerase I |
| 06/26/2001 | US6251385 Antigen stimulated cells for cancer treatment, free of bodily fluids |
| 06/26/2001 | US6251380 Extraction of plants with methanol, dichloromethane, ethyl acetate, mixing and drying then dilution |
| 06/22/2001 | CA2329296A1 Method for immobilizing allergens |
| 06/22/2001 | CA2328356A1 Recreational vehicles |
| 06/21/2001 | WO2001044489A2 Galactomannan oligosaccharides and methods for the production and use thereof |
| 06/21/2001 | WO2001044475A1 Novel polypeptide and dna thereof |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044465A2 Therapeutically useful synthetic oligonucleotides |
| 06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044286A2 Five-helix protein |
| 06/21/2001 | WO2001044278A2 Antigen preparations |
| 06/21/2001 | WO2001044268A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 06/21/2001 | WO2001044264A2 Novel stromelysin inhibitors |
| 06/21/2001 | WO2001044254A1 Cyclopenteneone derivatives |
| 06/21/2001 | WO2001044248A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | WO2001044246A1 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044245A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044217A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044213A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | WO2001044206A1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044203A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001044170A1 Adamantane derivatives |
| 06/21/2001 | WO2001044164A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | WO2001043775A2 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | WO2001043773A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 06/21/2001 | WO2001043772A2 Method and device for producing an autologous immunization vaccine against cancerous diseases (tumour vaccine) |
| 06/21/2001 | WO2001043771A1 Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory iga's |
| 06/21/2001 | WO2001043770A2 Method for enhancing immune responses in mammals |
| 06/21/2001 | WO2001043769A2 Antigen delivery |
| 06/21/2001 | WO2001043761A2 Methods for treating and preventing damage to mucosal tissue |
| 06/21/2001 | WO2001043738A1 Method for detecting nucleotide synthesis inhibitors having fewer side effects |
| 06/21/2001 | WO2001043726A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | WO2001043720A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | WO2001043695A2 Peptide constructs for treating autoimmune and related diseases |
| 06/21/2001 | WO2001043694A2 Compositions and methods for caspase-induced apoptosis |
| 06/21/2001 | WO2001043691A2 Fragments and antagonists of heat shock protein 60 |